Modifying Dendritic Cell Activation with Plasmonic Nano Vectors

Dendritic cells (DCs) can acquire, process, and present antigens to T-cells to induce an immune response. For this reason, targeting cancer antigens to DCs in order to cause an immune response against cancer is an emerging area of nanomedicine that has the potential to redefine the way certain cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Vang, Kieng Bao, Safina, Ingrid, Darrigues, Emilie, Nedosekin, Dmitry, Nima, Zeid A., Majeed, Waqar, Watanabe, Fumiya, Kannarpady, Ganesh, Kore, Rajshekhar A., Casciano, Daniel, Zharov, Vladimir P., Griffin, Robert J., Dings, Ruud P. M., Biris, Alexandru S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511287/
https://www.ncbi.nlm.nih.gov/pubmed/28710434
http://dx.doi.org/10.1038/s41598-017-04459-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511287/
https://www.ncbi.nlm.nih.gov/pubmed/28710434
http://dx.doi.org/10.1038/s41598-017-04459-1

Ejemplares similares